ApprovalTrail

Approval · Notice of Compliance 30866 · 2023

ALERTEC: Notice of Compliance 30866

Issued May 31, 2023

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
30866
Date
May 31, 2023
Company
Teva Canada LimitedToronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Addition of an alternate container closure system

Products in this notice

BrandDINStatus today
ALERTECNot yet assigned—

Medicinal ingredients